These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 6979499

  • 1. [Thrombocyte function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 1. Pathogenesis, prevention, therapy].
    Marshall M.
    Fortschr Med; 1982 Apr 15; 100(14):650-5. PubMed ID: 6979499
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
    Angelkort B.
    Med Welt; 1979 Aug 24; 30(34):1239-43. PubMed ID: 491921
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of ultraviolet ray irradiation of blood on thrombocyte function and cholesterol level].
    Frick G, Frick U, Wiedenhöft I.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983 Aug 24; 110(2):258-67. PubMed ID: 6194059
    [Abstract] [Full Text] [Related]

  • 8. Platelets of patients with peripheral arterial disease demonstrate a hypersensitive response to heparin.
    Reininger CB, Greinacher A, Eibl-Eibesfeldt B, Lasser R, Steckmeier B, Schweiberer L.
    Int Angiol; 1996 Sep 24; 15(3):207-14. PubMed ID: 8971577
    [Abstract] [Full Text] [Related]

  • 9. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
    Wong S, Morel-Kopp MC, Chen Q, Appleberg M, Ward CM, Lewis DR.
    Thromb Haemost; 2006 Jun 24; 95(6):1042-3. PubMed ID: 16732389
    [No Abstract] [Full Text] [Related]

  • 10. [Platelet function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 2. Secondary prevention].
    Marshall M.
    Fortschr Med; 1982 May 13; 100(18):825-30. PubMed ID: 7095698
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Inhibition of induced thrombocyte aggregation by adenosine and adenosine derivatives. 2. Correlation between inhibition of aggregation and peripheral vasodilatation].
    Dietmann K, Birkenheier H, Schaumann W.
    Arzneimittelforschung; 1970 Nov 13; 20(11):1749-51. PubMed ID: 5536984
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment strategies in arterial occlusive diseases].
    Bollinger A.
    Schweiz Rundsch Med Prax; 1993 Nov 23; 82(47):1354-8. PubMed ID: 8272701
    [Abstract] [Full Text] [Related]

  • 19. The impact of peripheral arterial disease on circulating platelets.
    McBane RD, Karnicki K, Miller RS, Owen WG.
    Thromb Res; 2004 Nov 23; 113(2):137-45. PubMed ID: 15115669
    [Abstract] [Full Text] [Related]

  • 20. Peripheral arterial disease: drug therapy.
    Schwartz JB.
    J Gend Specif Med; 2002 Nov 23; 5(4):16-20. PubMed ID: 12192882
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.